U.S. Physical Therapy, Inc. (FRA:UPH)
Germany · Delayed Price · Currency is EUR 68.00
-1.00 (-1.45%)
Last updated: Jan 29, 2026, 8:04 AM CET
U.S. Physical Therapy Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 623.05 | 553.64 | 508.38 | 459.04 | 433.03 | 368.72 |
Other Revenue | 127.9 | 110.79 | 90.25 | 88.55 | 56.69 | 49.63 |
| 750.95 | 664.43 | 598.63 | 547.6 | 489.72 | 418.35 | |
Revenue Growth (YoY) | 17.51% | 10.99% | 9.32% | 11.82% | 17.06% | -12.32% |
Cost of Revenue | 586.04 | 518.3 | 461.99 | 421.56 | 372.54 | 323.9 |
Gross Profit | 164.91 | 146.13 | 136.64 | 126.04 | 117.18 | 94.45 |
Selling, General & Admin | 66.71 | 58.29 | 51.95 | 46.11 | 46.53 | 42.04 |
Operating Expenses | 89.01 | 76.14 | 66.91 | 60.05 | 46.53 | 42.04 |
Operating Income | 75.9 | 69.99 | 69.73 | 65.99 | 70.65 | 52.41 |
Interest Expense | -9.16 | -8.02 | -9.3 | -5.78 | -0.94 | -1.63 |
Interest & Investment Income | 0.39 | 3.94 | 3.77 | - | - | 0.14 |
Earnings From Equity Investments | 1.42 | 1.01 | 0.96 | 1.18 | 0.11 | - |
Other Non Operating Income (Expenses) | -0.91 | 0.28 | 2.97 | 0.85 | 1.42 | - |
EBT Excluding Unusual Items | 67.64 | 67.2 | 68.13 | 62.24 | 71.23 | 50.92 |
Merger & Restructuring Charges | -0.52 | -4.36 | -0.18 | -0.07 | - | - |
Impairment of Goodwill | - | - | -17.5 | -9.11 | - | - |
Gain (Loss) on Sale of Investments | -0.12 | - | - | - | - | 1.09 |
Asset Writedown | -2.42 | -2.42 | - | - | - | - |
Legal Settlements | - | - | - | - | -2.64 | - |
Other Unusual Items | 16.6 | -0.22 | -1.08 | 2.52 | 4.6 | 13.5 |
Pretax Income | 81.18 | 60.21 | 49.38 | 55.57 | 73.2 | 65.51 |
Income Tax Expense | 19.85 | 14.61 | 12.16 | 12.16 | 15.27 | 13.02 |
Earnings From Continuing Operations | 61.32 | 45.6 | 37.22 | 43.41 | 57.92 | 52.49 |
Minority Interest in Earnings | -16.65 | -14.18 | -8.98 | -11.25 | -17.09 | -17.3 |
Net Income | 44.67 | 31.42 | 28.24 | 32.16 | 40.83 | 35.19 |
Preferred Dividends & Other Adjustments | 8.66 | 3.7 | 10.1 | 2.9 | 9.69 | 3.42 |
Net Income to Common | 36.02 | 27.73 | 18.14 | 29.26 | 31.14 | 31.78 |
Net Income Growth | 95.63% | 11.28% | -12.19% | -21.24% | 16.02% | -12.10% |
Shares Outstanding (Basic) | 15 | 15 | 14 | 13 | 13 | 13 |
Shares Outstanding (Diluted) | 15 | 15 | 14 | 13 | 13 | 13 |
Shares Change (YoY) | 0.77% | 6.17% | 9.26% | 0.68% | 0.49% | 0.62% |
EPS (Basic) | 2.38 | 1.84 | 1.28 | 2.25 | 2.41 | 2.48 |
EPS (Diluted) | 2.38 | 1.84 | 1.28 | 2.25 | 2.41 | 2.48 |
EPS Growth | 153.49% | 43.97% | -43.27% | -6.49% | -2.66% | 1.06% |
Free Cash Flow | 56.9 | 65.75 | 72.68 | 50.29 | 68.21 | 92.36 |
Free Cash Flow Per Share | 3.75 | 4.37 | 5.12 | 3.87 | 5.29 | 7.20 |
Dividend Per Share | 1.790 | 1.760 | 1.720 | 1.640 | 1.460 | 0.320 |
Dividend Growth | 2.29% | 2.33% | 4.88% | 12.33% | 356.25% | -71.93% |
Gross Margin | 21.96% | 21.99% | 22.83% | 23.02% | 23.93% | 22.58% |
Operating Margin | 10.11% | 10.53% | 11.65% | 12.05% | 14.43% | 12.53% |
Profit Margin | 4.80% | 4.17% | 3.03% | 5.34% | 6.36% | 7.60% |
Free Cash Flow Margin | 7.58% | 9.90% | 12.14% | 9.18% | 13.93% | 22.08% |
EBITDA | 99.34 | 88.67 | 85.43 | 80.73 | 82.24 | 62.95 |
EBITDA Margin | 13.23% | 13.35% | 14.27% | 14.74% | 16.79% | 15.05% |
D&A For EBITDA | 23.44 | 18.68 | 15.7 | 14.74 | 11.59 | 10.53 |
EBIT | 75.9 | 69.99 | 69.73 | 65.99 | 70.65 | 52.41 |
EBIT Margin | 10.11% | 10.53% | 11.65% | 12.05% | 14.43% | 12.53% |
Effective Tax Rate | 24.46% | 24.26% | 24.62% | 21.89% | 20.87% | 19.88% |
Revenue as Reported | 671.35 | 671.35 | 604.8 | 553.14 | 495.02 | 422.97 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.